1,4-benzodiazepinone compounds and their use in treating cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8604023
APP PUB NO 20120094982A1
SERIAL NO

13263962

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides a family of 1,4-benzodiazepinone compounds and methods for their use as therapeutic agents in treating cancer. Pharmaceutical compositions and methods of making the 1,4-benzodiazepinone compounds are provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • THE REGENTS OF THE UNIVERSITY OF MICHIGAN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Glick, Gary D Ann Arbor, US 80 1088
Taylor, Clarke Bentley Ann Arbor, US 2 8
Toogood, Peter Laurence Ann Arbor, US 24 449
Van, Huis Chad Alan Plymouth, US 7 37

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 10, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00